Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Fleckenstein

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Neuropharmacology|February 4, 2015
Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposureLisa M McFadden, Paula L Vieira-Brock, Glen R Hanson, et al.
Behavioural Pharmacology|October 18, 2014
Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in ratsMichelle G Baladi, Shannon M Nielsen, Anthony Umpierre, et al.
Journal of Neurochemistry|February 18, 2011
Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatmentMario E Alburges, Amanda J Hoonakker, Kristen A Horner, et al.
Journal of Neuroscience Methods|February 5, 2011
Ex vivo identification of protein-protein interactions involving the dopamine transporterGregory C Hadlock, Chad C Nelson, Anthony J Baucum, et al.
Annals of the New York Academy of Sciences|November 16, 2006
Age-dependent effects of methamphetamine on VMAT-2Kristi S Rau, Jannine G Truong, Diana G Wilkins, et al.
Annual Review of Pharmacology and Toxicology|January 11, 2007
New insights into the mechanism of action of amphetaminesAnnette E Fleckenstein, Trent J Volz, Evan L Riddle, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2008
Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptorsTrent J Volz, Sarah J Farnsworth, Shane D Rowley, et al.
European Journal of Pharmacology|August 7, 2002
Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaineEvan L Riddle, Matthew K Topham, John W Haycock, et al.
European Journal of Pharmacology|December 25, 2002
Ceramide-induced alterations in dopamine transporter functionEvan L Riddle, Kristi S Rau, Matthew K Topham, et al.
Annals of the New York Academy of Sciences|November 2, 2017
Methamphetamine-Induced Rapid and Reversible Reduction in the Activities of Tryptophan Hydroxylase and Dopamine Transporters: Oxidative Consequences?<sup>a</sup>Glen R Hanson, James W Gibb, Ryan R Metzger, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Neuropharmacology|February 4, 2015
Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposureLisa M McFadden, Paula L Vieira-Brock, Glen R Hanson, et al.
Behavioural Pharmacology|October 18, 2014
Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in ratsMichelle G Baladi, Shannon M Nielsen, Anthony Umpierre, et al.
Journal of Neurochemistry|February 18, 2011
Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatmentMario E Alburges, Amanda J Hoonakker, Kristen A Horner, et al.
Journal of Neuroscience Methods|February 5, 2011
Ex vivo identification of protein-protein interactions involving the dopamine transporterGregory C Hadlock, Chad C Nelson, Anthony J Baucum, et al.
Annals of the New York Academy of Sciences|November 16, 2006
Age-dependent effects of methamphetamine on VMAT-2Kristi S Rau, Jannine G Truong, Diana G Wilkins, et al.
Annual Review of Pharmacology and Toxicology|January 11, 2007
New insights into the mechanism of action of amphetaminesAnnette E Fleckenstein, Trent J Volz, Evan L Riddle, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 2, 2008
Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptorsTrent J Volz, Sarah J Farnsworth, Shane D Rowley, et al.
European Journal of Pharmacology|August 7, 2002
Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaineEvan L Riddle, Matthew K Topham, John W Haycock, et al.
European Journal of Pharmacology|December 25, 2002
Ceramide-induced alterations in dopamine transporter functionEvan L Riddle, Kristi S Rau, Matthew K Topham, et al.
Annals of the New York Academy of Sciences|November 2, 2017
Methamphetamine-Induced Rapid and Reversible Reduction in the Activities of Tryptophan Hydroxylase and Dopamine Transporters: Oxidative Consequences?<sup>a</sup>Glen R Hanson, James W Gibb, Ryan R Metzger, et al.
Pageof 8